Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective.
about
Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer.Incorporating 18FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation.The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer
P2860
Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Hematologic toxicity in anal c ...... iation oncologist perspective.
@ast
Hematologic toxicity in anal c ...... iation oncologist perspective.
@en
type
label
Hematologic toxicity in anal c ...... iation oncologist perspective.
@ast
Hematologic toxicity in anal c ...... iation oncologist perspective.
@en
prefLabel
Hematologic toxicity in anal c ...... iation oncologist perspective.
@ast
Hematologic toxicity in anal c ...... iation oncologist perspective.
@en
P2093
P2860
P1476
Hematologic toxicity in anal c ...... diation oncologist perspective
@en
P2093
Francesca Arcadipane
Mario Morino
Massimiliano Mistrangelo
Paola Cassoni
Patrizia Racca
Pierfrancesco Franco
Riccardo Ragona
Umberto Ricardi
P2860
P304
P356
10.1080/14737140.2017.1288104
P577
2017-02-17T00:00:00Z